An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate
Clinical trial NCT02520557 · TERMINATED
Trial details
- NCT number
- NCT02520557
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-30
- Primary completion
- 2020-01-21
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.